Sanofi said this morning ... this year from an ever-lengthening list of indications associated with type 2 inflammation. The three pipelines-in-a-product are anti-OX40 antibody amlitelimab ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

Sanofi SNY has entered into exclusive negotiations ... Opella’s current portfolio of products includes brands such as Allegra, Doliprane and Dulcolax. The above transaction will classify Opella ...

PARIS, Oct 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton ...